Literature DB >> 23519970

Roles of versican in cancer biology--tumorigenesis, progression and metastasis.

William Weidong Du1, Weining Yang, Albert J Yee.   

Abstract

Versican, a large extracellular matrix proteoglycan accumulates in tumor stroma and plays a key role in both malignant transformation and tumor progression. Increased versican expression has been observed in a wide range of malignant tumors, and has been associated with both cancer relapse and poor patient outcomes in breast, prostate, and many other cancer types. Through negatively-charged chondroitin and dermatan sulfate side chains or interactions of the G1 and G3 domains, versican is able to regulate many cellular processes including cell adhesion, proliferation, apoptosis, migration, angiogenesis, invasion and metastasis. In this review, the biological roles that versican plays in cancer development are presented. Therapeutic targeting of versican in malignant tumors is also discussed.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23519970     DOI: 10.14670/HH-28.701

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  37 in total

1.  Versican-Derived Matrikines Regulate Batf3-Dendritic Cell Differentiation and Promote T Cell Infiltration in Colorectal Cancer.

Authors:  Chelsea Hope; Philip B Emmerich; Athanasios Papadas; Adam Pagenkopf; Kristina A Matkowskyj; Dana R Van De Hey; Susan N Payne; Linda Clipson; Natalie S Callander; Peiman Hematti; Shigeki Miyamoto; Michael G Johnson; Dustin A Deming; Fotis Asimakopoulos
Journal:  J Immunol       Date:  2017-07-28       Impact factor: 5.422

2.  Versican Promotes Tumor Progression, Metastasis and Predicts Poor Prognosis in Renal Carcinoma.

Authors:  Yozo Mitsui; Hiroaki Shiina; Taku Kato; Shigekatsu Maekawa; Yutaka Hashimoto; Marisa Shiina; Mitsuho Imai-Sumida; Priyanka Kulkarni; Pritha Dasgupta; Ryan Kenji Wong; Miho Hiraki; Naoko Arichi; Shinichiro Fukuhara; Soichiro Yamamura; Shahana Majid; Sharanjot Saini; Guoren Deng; Rajvir Dahiya; Koichi Nakajima; Yuichiro Tanaka
Journal:  Mol Cancer Res       Date:  2017-02-27       Impact factor: 5.852

Review 3.  Versican and the regulation of cell phenotype in disease.

Authors:  Thomas N Wight; Michael G Kinsella; Stephen P Evanko; Susan Potter-Perigo; Mervyn J Merrilees
Journal:  Biochim Biophys Acta       Date:  2014-01-05

4.  Three-dimensional culture system identifies a new mode of cetuximab resistance and disease-relevant genes in colorectal cancer.

Authors:  Cunxi Li; Bhuminder Singh; Ramona Graves-Deal; Haiting Ma; Alina Starchenko; William H Fry; Yuanyuan Lu; Yang Wang; Galina Bogatcheva; Mohseen P Khan; Ginger L Milne; Shilin Zhao; Gregory Daniel Ayers; Nenggan Li; Huaying Hu; Mary Kay Washington; Timothy J Yeatman; Oliver G McDonald; Qi Liu; Robert J Coffey
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-20       Impact factor: 11.205

Review 5.  Extracellular matrix and the myeloid-in-myeloma compartment: balancing tolerogenic and immunogenic inflammation in the myeloma niche.

Authors:  Fotis Asimakopoulos; Chelsea Hope; Michael G Johnson; Adam Pagenkopf; Kimberly Gromek; Bradley Nagel
Journal:  J Leukoc Biol       Date:  2017-03-02       Impact factor: 4.962

6.  Versican upregulation in Sézary cells alters growth, motility and resistance to chemotherapy.

Authors:  K Fujii; M B Karpova; K Asagoe; O Georgiev; R Dummer; M Urosevic-Maiwald
Journal:  Leukemia       Date:  2015-04-27       Impact factor: 11.528

7.  Sarcoma Tumor Microenvironment.

Authors:  Panagiotis Tsagozis; Jordi Gonzalez-Molina; Anna-Maria Georgoudaki; Kaisa Lehti; Joseph Carlson; Andreas Lundqvist; Felix Haglund; Monika Ehnman
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

8.  TPL2 kinase regulates the inflammatory milieu of the myeloma niche.

Authors:  Chelsea Hope; Samuel J Ollar; Erika Heninger; Ellen Hebron; Jeffrey L Jensen; Jaehyup Kim; Ioanna Maroulakou; Shigeki Miyamoto; Catherine Leith; David T Yang; Natalie Callander; Peiman Hematti; Marta Chesi; P Leif Bergsagel; Fotis Asimakopoulos
Journal:  Blood       Date:  2014-04-10       Impact factor: 22.113

Review 9.  Provisional matrix: A role for versican and hyaluronan.

Authors:  Thomas N Wight
Journal:  Matrix Biol       Date:  2016-12-06       Impact factor: 11.583

10.  Prostate cancer cells specifically reorganize epithelial cell-fibroblast communication through proteoglycan and junction pathways.

Authors:  Anastasia V Suhovskih; Vladimir I Kashuba; George Klein; Elvira V Grigorieva
Journal:  Cell Adh Migr       Date:  2016-04-25       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.